Discover verified cancer discoveries

Search and filter stories that passed editorial review. Evidence strength, regulatory status, and guideline position are shown separately and are never inferred from one another.

Filter discoveries

Results

Active filters:Clear all

1 verified discovery matches your filters.

FDA approves zolbetuximab for CLDN18.2-positive gastric and gastroesophageal junction cancer

Evidence stage: High-Certainty EvidenceRegulatory status: FDA Approved
Cancer type
Stomach (Gastric) Cancer
Published
August 13, 2026

In two separate, randomized, double-blind, phase 3 trials (SPOTLIGHT and GLOW), adding zolbetuximab to first-line chemotherapy significantly extended both progression-free survival and overall survival, compared with chemotherapy alone, in patients…

Primary source cited

Last reviewed